RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis.
Several viruses are causing illnesses in Ohio and the U.S. See the symptoms for COVID-19, RSV, flu, norovirus and bird flu.
“The last several weeks we’ve started to see a definite increase in influenza-like illnesses, which cover influenza, RSV, ...
Influenza A, COVID-19 and norovirus (stomach flu) are on the rise, according to the Centers for Disease Control and ...
Hosted on MSN13h
FDA Adds Guillain-Barre Syndrome Warning to Two RSV VaccinesBefore the RSV vaccines were approved, the FDA flagged potential GBS risks with the vaccines. After approval, the CDC ...
Eight in 10 infants received respiratory syncytial virus (RSV) protection during the 2023 to 2024 season, according ...
The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...
“As of December 28, Oneida County has had 386 flu cases reported since the flu season began,” said Daniel W. Gilmore, Ph.D., ...
Findings from a postmarketing observational study showed an increased risk of GBS during the 42 days following vaccination.
Vaccines and monoclonal antibodies are reducing RSV hospitalizations, but high costs and limited access in low-income ...
For RSV in particular, nearly two dozen states are currently reporting high levels, according to the U.S. Centers for Disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback